- Supported exchanges /
- F /
- 8I7.F
GEMINA LABS LTD (8I7 F) stock market data APIs
€0.555
0(0%)
as of November 26, 2024
Price chart is built with Anychart
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.
GEMINA LABS LTD Financial Data Overview
| 0.555 | |
| 0.555 | |
| - | |
| 0.555 | |
| 0.555 | |
| 0.172-0.555 | |
| 41 389 K | |
| 74 574 K | |
| -5 443 | |
| 0.095 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'8I7',
Type:
'Common Stock',
Name:
'GEMINA LABS LTD',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'CA3686501071',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'January',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
GEMINA LABS LTD Fundamental Data is available in our Financial Data APIs
- Net Revenue -5 443
- EBITDA -3 588 245
- Earnings Per Share -0.03
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get GEMINA LABS LTD Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get GEMINA LABS LTD End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
